Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 63   

Articles published

TENX 3.65 +0.07 (1.96%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Mid-Day Changers: Carter's, Inc. (CRI), Tenax Therapeutics, Inc. (TENX ...
Carter's, Inc. (CRI) of the Consumer Goods sector has changed by 1.82% and at noon is trading with a volume of 284,164 shares with a volatility this week of 1.49%.
Tenax Therapeutics to Present at Cowen & Company 35th Annual Health Care ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, ...
Tenax Therapeutics Announces Analyst Day and Webcast on April 13, 2015
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the company will ...
Hot Watch List: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Tenax ...
Tenax Therapeutics, Inc. (NASDAQ:TENX) shares advanced 0.86% in last trading session and ended the day at $3.53. TENX return on assets is -38.30%.
Tenax Therapeutics Provides Clinical and Corporate Update
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today provided an update regarding ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Tenax Therapeutics Announces Appointment of Paula Bokesch, MD, as Chief ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »  
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX).
Related articles »